eMedicine Specialties > Neurosurgery > Vascular

Caroticocavernous Fistula: Treatment

Author: Michael G Nosko, MD, PhD, Chief, Division of Neurosurgery, Director of Neurovascular Surgery, Medical Director of Neuroscience Unit, Associate Professor, Department of Surgery, University of Medicine and Dentistry at New Jersey
Contributor Information and Disclosures

Updated: May 27, 2009

Treatment

Medical Therapy

In the acute setting of vision loss and/or paralysis of cranial nerves, glucocorticosteroids (eg, dexamethasone) may be used while waiting for definitive diagnostic studies and treatments.

Surgical Therapy

The definitive management of a caroticocavernous fistula is obliteration of the fistulous connection with restoration of normal arterial and venous flow. This is achieved most often through an endovascular approach. After complete delineation of the fistulous tract, an approach can be planned to close the fistula.

Type-A fistulas usually are approached through the internal carotid artery. A detachable balloon then can be positioned to occlude the fistula while maintaining patency of the internal carotid artery. Venous approaches through the internal jugular vein and the petrosal sinus may allow access to the fistula from the venous side. Guglielmi detachable coils also may be used and are becoming increasingly popular.

Type B, C, and D fistulas have smaller fistulous connections and usually are not amenable to the aforementioned treatment approaches. Carotid self-compression for 20-30 seconds 4 times per hour may lead to thrombosis of the fistula. Patients are instructed to compress the carotid artery on the side of the lesion using their contralateral hand. Should the patient develop cerebral ischemia during the compression, the contralateral hand likely will be affected, releasing the compression.

If compression is not effective or if a more rapid intervention is indicated, selective endovascular embolization of the fistula through the external carotid artery usually is effective. Several choices of embolic material are available, although polyvinyl alcohol usually is preferred.

Occasionally a fistula may require an endovascular approach through the superior ophthalmic vein. This requires surgical exposure of the vein to allow placement of the catheter.

Direct surgical exposure and obliteration of the fistula has been described. This rarely is indicated because endovascular approaches have been developed.

Severely refractory fistulas can be treated by surgical or endovascular sacrifice of the internal carotid artery. This too, rarely is indicated.

Follow-up

Patients usually require a follow-up angiogram to ensure that the fistula has not recurred or that alternate fistulous pathways have not developed.

Complications

Complications in untreated lesions usually are limited to visual loss, cranial nerves paralysis, and the cosmetic concerns of proptosis.

Complications of treatment include the standard complications of cerebral angiography. Arterial and venous compromise also may occur, yielding cerebral or retinal ischemia and resultant infarction.

More on Caroticocavernous Fistula

Overview: Caroticocavernous Fistula
Workup: Caroticocavernous Fistula
Treatment: Caroticocavernous Fistula
Follow-up: Caroticocavernous Fistula
Multimedia: Caroticocavernous Fistula
References

References

  1. Barrow DL, Spector RH, Braun IF. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg. Feb 1985;62(2):248-56. [Medline].

  2. Karaman E, Isildak H, Haciyev Y, Kaytaz A, Enver O. Carotid-cavernous fistula after functional endoscopic sinus surgery. J Craniofac Surg. Mar 2009;20(2):556-8. [Medline].

  3. Hieshima GB, Cahan LD, Mehringer CM. Spontaneous arteriovenous fistulas of cerebral vessels in association with fibromuscular dysplasia. Neurosurgery. Apr 1986;18(4):454-8. [Medline].

  4. Bacon KT, Duchesneau PM, Weinstein MA. Demonstration of the superior ophthalmic vein by high resolution computed tomography. Radiology. Jul 1977;124(1):129-31. [Medline].

  5. Dandy WE, Follis RH Jr. On the pathology of carotid-cavernous aneurysms (pulsating exophthalmos). Am J Ophthalmol. 1941;24:365-385.

  6. Debrun GM, Vinuela F, Fox AJ. Indications for treatment and classification of 132 carotid-cavernous fistulas. Neurosurgery. Feb 1988;22(2):285-9. [Medline].

  7. Hamby WB. Carotid-cavernous fistula. Springfield, Ill: Charles C Thomas. 1966.

  8. Newton TH, Hoyt WF. Dural arteriovenous shunts in the region of the cavernous sinus. Neuroradiology. 1970;1:71-81.

  9. Serbinenko FA. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg. Aug 1974;41(2):125-45. [Medline].

  10. Walker AE, Allegre GE. Carotid-cavernous fistulas. Surgery. 1956;39:411-422.

Further Reading

Keywords

caroticocavernous fistula, cc fistula, dural arteriovenous fistula, arteriovenous shunting, type A caroticocavernous fistulas, type B caroticocavernous fistulas, type C caroticocavernous fistulas, type D caroticocavernous fistulas, intracavernous vessels, intracavernous arteries, intracavernous aneurysm, fibromuscular dysplasia, Ehlers-Danlos syndrome, collagen vascular diseases, atherosclerotic vascular disease, ophthalmic venous hypertension, orbital venous congestion, proptosis, chemosis, arterialization of episcleral veins, diplopia, visual loss, III cranial nerve palsy, IV cranial nerve palsy, V cranial nerve palsy, VI cranial nerve palsy, cranial nerve paralysis, central retinal vein occlusion, retinopathy, glaucoma, bruit, headache, visual loss, intracavernous internal carotid artery, cavernous sinus, dural shunt

Contributor Information and Disclosures

Author

Michael G Nosko, MD, PhD, Chief, Division of Neurosurgery, Director of Neurovascular Surgery, Medical Director of Neuroscience Unit, Associate Professor, Department of Surgery, University of Medicine and Dentistry at New Jersey
Michael G Nosko, MD, PhD is a member of the following medical societies: Academy of Medicine of New Jersey, Alpha Omega Alpha, American Association of Neurological Surgeons, American College of Surgeons, American Heart Association, American Medical Association, New York Academy of Sciences, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

Duc Hoang Duong, MD, Professor, Chief Physician, Departments of Neurological Surgery and Neuroscience, Epilepsy Center, Charles Drew University of Medicine and Science
Duc Hoang Duong, MD is a member of the following medical societies: American Neurological Association, Congress of Neurological Surgeons, and North American Skull Base Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ryszard M Pluta, MD, PhD, Associate Professor, Neurosurgical Department Medical Research Center, Polish Academy of Sciences at Warsaw, Poland; Senior Researcher, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH
Ryszard M Pluta, MD, PhD is a member of the following medical societies: Congress of Neurological Surgeons and Polish Society of Neurosurgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.